ARDX
Ardelyx Inc
NASDAQ: ARDX · HEALTHCARE · BIOTECHNOLOGY
$6.01
+0.67% today
Updated 2026-04-29
Market cap
$1.47B
P/E ratio
—
P/S ratio
3.62x
EPS (TTM)
$-0.26
Dividend yield
—
52W range
$3 – $8
Volume
3.6M
Ardelyx Inc (ARDX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-15.10%
Operating margin
4.07%
ROE
-36.20%
ROA
-5.46%
Debt/equity
1.27x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $5.41M | $-9.79M | 64.66% | -162.75% | -180.87% |
| 2013 | $28.93M | $-6.56M | 2.89% | -9.90% | -22.69% |
| 2014 | $31.62M | $-3.21M | 100.00% | -4.95% | -10.16% |
| 2015 | $24.03M | $-29.62M | 100.00% | -122.32% | -123.29% |
| 2016 | $24.03M | $-112.39M | 94.61% | -469.89% | -467.77% |
| 2017 | $42.00M | $-64.34M | 80.00% | -155.04% | -153.19% |
| 2018 | $2.61M | $-91.30M | 82.13% | -3,488.57% | -3,502.03% |
| 2019 | $5.28M | $-94.94M | 88.64% | -1,728.14% | -1,797.77% |
| 2020 | $7.57M | $-94.31M | 98.08% | -1,199.05% | -1,245.71% |
| 2021 | $10.10M | $-158.16M | 90.10% | -1,528.63% | -1,566.46% |
| 2022 | $52.16M | $-67.21M | 92.11% | -122.24% | -128.85% |
| 2023 | $124.46M | $-66.07M | 85.70% | -50.84% | -53.08% |
| 2024 | $333.62M | $-39.14M | 84.85% | -8.38% | -11.73% |
| 2025 | $407.32M | $-61.60M | 90.29% | -10.06% | -15.12% |